Keyphrases
Newborn Screening
100%
COVID-19
63%
K-12
58%
Genetic Testing
50%
Whole Genome Sequencing
47%
Genetic Diagnosis
47%
COVID-19 Testing
44%
Somatic Mosaicism
41%
Developmental Delay
40%
School-based
39%
Mitigation Strategies
34%
Population-based Study
33%
Testing Strategy
33%
Microcephaly
33%
Cluster Randomized Trial
33%
Underserved Populations
33%
Medium-chain acyl-CoA Dehydrogenase Deficiency
33%
Diagnostic Performance
29%
SARS-CoV-2 Transmission
28%
Clinical Laboratory
28%
Jewish Population
25%
SARS-CoV-2 Testing
25%
Next-generation Sequencing
25%
Carnitine Level
25%
Clinical Characteristics
25%
X Chromosome Inactivation
25%
Tumor
24%
Acute Myeloid Leukemia
23%
Likely Pathogenic Variant
22%
Missouri
22%
School Districts
22%
Late-onset
22%
Clinical Indications
20%
Vertebral Body
20%
Screening Test
20%
Biochemical Genetics
20%
Carrier Screening
20%
Pathogenic Variants
20%
Saliva-based
19%
In Cancer
19%
K-12 Students
19%
Diagnostic Utility
19%
St. Louis
19%
Kindergarten
19%
L-carnitine
19%
Whole Exome Sequencing
19%
Fluorescence in Situ Hybridization
19%
Diagnostic Test
19%
Gene Sequencing
18%
Primary Care Providers
16%
Biochemistry, Genetics and Molecular Biology
Genetics
95%
Genomics
56%
Newborn Screening
50%
Whole Genome Sequencing
45%
Mosaicism
44%
Next Generation Sequencing
38%
Karyotype
38%
Exome Sequencing
37%
Myeloid
33%
Cytogenetics
33%
Genetic Screening
33%
X-Inactivation
33%
Clinical Trial
24%
X Chromosome
23%
DNA Sequence
22%
Fluorescence in Situ Hybridization
20%
Gene Sequence
18%
HMGB1
16%
Cluster Randomized Trial
16%
DNA Mismatch Repair
16%
Genome Sequencing
16%
Genome-Wide Association Study
16%
NUP98
16%
Array Comparative Genomic Hybridization
16%
CD8
16%
Programmed Cell Death 1
16%
T Cell
16%
Embryo Transfer
16%
Hexosaminidase
16%
Enzyme
16%
Obligate Carrier
16%
Restriction Fragment Length Polymorphism
16%
Blood Level
16%
Genetic Prenatal Diagnosis
16%
Heterozygosity
16%
Trisomy 18
16%
BRCA1
16%
Tay-Sachs Disease
16%
Molecular Lesion
16%
Homocystinuria
16%
B Cell
16%
Chromosomal Abnormalities
16%
Blood Plasma
16%
Acyl-CoA
16%
Trisomy
16%
Maternal Age
16%
Nondisjunction
16%
Short-Chain Acyl-CoA Dehydrogenase
16%
BRCA2
16%
Serine
16%
Medicine and Dentistry
Newborn Screening
83%
Carnitine
47%
Genetic Screening
33%
Carboxylase
33%
Congenital Malformation
33%
Diseases
30%
Diagnosis
19%
X Chromosome
18%
Racial Disparity
16%
Outpatient
16%
Next Generation Sequencing
16%
Nose Smear
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Fluorescence in Situ Hybridization
16%
Arteriovenous Malformation
16%
Acute Myeloid Leukemia
16%
Whole Genome Sequencing
16%
Primary Health Care
16%
Bisphenol A
16%
Achondroplasia
16%
Crouzon Syndrome
16%
Ependymoma
16%
Methylcrotonyl-CoA
16%
Crotonyl-CoA
16%
Acyl Coenzyme A Dehydrogenase
16%
Dysostosis
16%
Dysplasia
16%
Ossification
16%
Fibroblast Growth Factor Receptor 3
16%
Acanthosis Nigricans
16%
Organic Acidemia
16%
Prenatal Diagnosis
16%
Methylmalonic aciduria
16%
Systematic Review
16%
Carboxylic Acid
16%
Pelvis
16%
Morphology
16%
Thyroid Gland
16%
Restriction Fragment Length Polymorphism
16%
Methylation
16%
Homocystinuria
16%
Aicardi Syndrome
16%
Enzyme Activity
16%
Screening
16%
Branchial Arch
16%
Agenesis
16%
Craniofacial Malformation
16%
Craniofacial Synostosis
16%
Fibroblast Growth Factor Receptor 1
16%
Neonatal Infant
13%
